Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
Measures the prevalence of positive and negative syndromes in schizophrenia.
A few points to consider when using this scale:
- Always assign the highest applicable rating for each variable.
- Ensure the patient understands the reference period and time frame, typically “past one week”.
- Variables are not based solely on patient interviews but can also incorporate input from third-party reporters.
Advice
- Scores can guide treatment decisions, including adjustments to antipsychotic choice or dosage.
- There is no consensus on what constitutes a clinically meaningful score change. Research settings have often used a 20–30% reduction as a marker of improvement; however, smaller changes may still be significant in clinical practice, particularly in individuals with severe or treatment-resistant disease.
- For patients with stable or improved scores, consider transitioning to less intensive monitoring.
- If scores indicate worsening, explore potential causes such as medication adherence issues, comorbidities, or psychosocial stressors, and adjust the treatment plan accordingly.